In 2017, the global single-lead ECG market was worth USD 337.08 millions. The market is expected to grow at a rate of 4.72% over the forecast period. These devices will be more popular if single-lead technology is used to monitor heart rate during exercise, sport activities, and training.
These devices will continue to grow in popularity due to the shift towards personalized health monitoring solutions. The market is also being driven by the rise of single-lead ECG monitoring devices that are mobile-based and smartphone-based.
Many entities have also integrated smartphone interoperability and ECG monitoring devices to offer users immediate and easy access to ECG waveforms. These practices can improve patient outcomes for cardiovascular disease treatment. These technological advances are expected to drive the market's growth over the forecast period.
Other than this, government initiatives that support remote monitoring equipment will likely encourage technological advancement in single-lead ECG/EKG technology. In the future, however, the market will be hindered by insecure reimbursement policies for cardiology services, particularly in developing countries.
In order to attract customer attention and encourage adoption, market participants participate in product enhancements. There are many issues to be faced, including the need for information management systems that allow results to be shared directly with doctors for consultation and interpretation. Initiatives based on customer-centricity will likely reduce such problems.
The rising prevalence of cardiovascular diseases is driving the demand for single-lead ECG/EKG units. The American Heart Association estimates that more than 4,000,000 patients suffer from arrhythmias, which causes about half a million deaths annually in the U.S.
The continuous research and development has resulted in the creation of single-lead ECG units that can be used to diagnose arrhythmias, syncope or monitor for potential cardiovascular problems. For instance, HeartScan ECG Monitor, manufactured by Omron Corporation can be used by patients suffering from diabetes, hypertension, hypercholesterolemia, and obesity to assess CVD risks.
These devices are now much easier to use thanks to cloud-based storage and artificial intelligence technology. These devices can reduce the need for clinic visits and the cost of monitoring. They also allow for a quick and accurate diagnosis. This allows patients to be monitored for presyncope or intermittent giddiness, which can then be used to determine if a pacemaker is needed before the onset of syncope.
The forecast period will see a significant increase in the usage of smartphones and tablets to access health-related apps. This is expected to lead to a boom in revenue for portable single-lead ECG devices for home and ambulatory services. Promotion of final products is encouraged through various social and health awareness platforms in order to increase product adoption.
This technology's cost-effectiveness will be a major advantage in home healthcare settings. These devices are primarily used to provide rhythm information and timing information. The prescription rate is reduced by certain limitations, such as inability to provide heart functions.
Due to the ongoing development in-home as well as ambulatory healthcare in the region, North America dominated 2017's global single-lead ECG market. This region also has a high rate of mortality due to cardiovascular disease, which drives up demand for home-use technology.
Asia Pacific will likely experience the fastest growth over the forecast period. The primary growth drivers for the region include emerging economies, growing use of wearable technology, improving infrastructure, and the presence in the target market.
Collaborations with the government are a key factor in India's growth. These collaborations aim to improve healthcare infrastructure and offer advanced primary care services. The market is expected to grow due to customers' increasing preference for mobile phone-associate devices.
Market leaders are actively involved in the introduction of new algorithms and products. Dimetek Digital Medical Technologies, Ltd., AliveCor, Inc., Tianjin Choice Electronic Tech Co., Ltd.; Perlong Medical Equipment Co., Limited. Ambisea Technology Corp., Ltd., SUZU.K.EN CO., Limited. (KENZ); Inc., Eurocamina, Longfian Scitech Co. Limited. DailyCare BioMedical, Inc., OMRON Corporation, Zenicor Medical Systems.
To increase product credibility, companies have taken several steps to conduct clinical studies. Market entities also work to generate evidence that will allow them to gain CE and FDA approval in the United States. This will help increase their market share. External competition to this technology are 12 portable ECG devices that can be used to monitor heart rate, and these are expected to hinder the growth.
This report provides a forecast of revenue growth at the country and regional levels, as well as an analysis of industry trends for each sub-segment from 2014 to 2025. Grand View Research has divided the global single-lead ECG equipment market report by indication, region, and end-use.
Indication Outlook (Revenue USD Million, 2014-2025)
Syncope
Arrhythmia
Atrial Fibrillation (AF)
Tachycardia
Bradycardia
Other Indications
End-Use Outlook (Revenue USD Million, 2014-2025)
Hospitals & Clinics
Home-care
Ambulatory Surgical Centers
Regional Outlook (Revenue USD Million, 2014-2025)
North America
The U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
Japan
China
Latin America
Brazil
MEA
South Africa
b. Global single-lead ECG market size was USD 374.3 Million in 2019, and is forecast to grow to USD 393.1 Million in 2020.
What is the single leading ecg market growth?b. Global single-lead ECG market to reach USD 487.6 millions by 2025 is expected to grow at 4.7% compound annual growth rate from 2018 to 2025.
Which segment had the largest market share for single-lead ecg equipment?b. With a market share of 42.4%, North America dominated single-lead ECG device markets in 2019, This can be attributed to the ongoing development in home and ambulatory healthcare in the region.
What are the major players in the single-lead ecg market?b. Dimetek Digital Medical Technologies, Ltd., AliveCor, Inc., Tianjin Choice Electronic Tech Co., Ltd., Perlong Medical Equipment Co., Limited, Ambisea Technology Corp., Ltd., SUZU.K.EN CO., Limited. (KENZ); Inc., Eurocamina, Longfian Scitech Co. Limited, DailyCare BioMedical, Inc., OMRON Corporation, Zenicor Medical Systems.
What are the driving factors for the single-lead ecg market?b. The market is driven by two key factors: growing popularity of homecare and shifting preference for cardiac assessment towards self–triaging before opting for complicated systems for analysis. This has led to the emergence of single-lead ECG monitors that can be used with smart phones and mobile devices.
Up Market Research published a new report titled “Single Lead ECG Equipment Market research report which is segmented by End Use (Hospitals & Clinics, Homecare, ASCs), by Indication (Syncope, Arrhythmia), By Players/Companies Inc, Limited (KENZ); Inc; Eurocamina; Longfian Scitech Co Limited; DailyCare BioMedical, Ltd; SUZUKEN CO, Zenicor Medical Systems, Dimetek Digital Medical Technologies, Limited; Ambisea Technology Corp, Ltd); Perlong Medical Equipment Co, Inc; Tianjin Chase Sun Pharmaceutical Group (Beijing Choice Electronic Tech Co, Ltd; AliveCor, OMRON Corporation”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Single Lead ECG Equipment Market Research Report |
By End Use | Hospitals & Clinics, Homecare, ASCs |
By Indication | Syncope, Arrhythmia |
By Companies | Inc, Limited (KENZ); Inc; Eurocamina; Longfian Scitech Co Limited; DailyCare BioMedical, Ltd; SUZUKEN CO, Zenicor Medical Systems, Dimetek Digital Medical Technologies, Limited; Ambisea Technology Corp, Ltd); Perlong Medical Equipment Co, Inc; Tianjin Chase Sun Pharmaceutical Group (Beijing Choice Electronic Tech Co, Ltd; AliveCor, OMRON Corporation |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 237 |
Number of Tables & Figures | 166 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by End Use (Hospitals & Clinics, Homecare, ASCs), by Indication (Syncope, Arrhythmia).
Single Lead ECG Equipment Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Single Lead ECG Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Single Lead ECG Equipment Market Report:
Some other reports from this category!